Noninvasive Retinal Functional Imaging of Animal Models
About the Research Project
Program
Award Type
Standard
Award Amount
$90,000
Active Dates
April 01, 2006 - March 31, 2008
Grant ID
G2006008
Summary
Neural tissue such as the brain or the retina of the eye exhibits a visible vascular response (an optical signal) when it is active, and sensitive cameras can be used to record these signals. This lab has recently adapted this technique to the non-invasive monitoring of retinal function. The promise of Dr. Ts’o project is the development of a reliable, objective instrument for monitoring the activity of the retina, in health and disease, simply by taking pictures of its response to patterns of light. Glaucoma is one disease that may greatly benefit from such an instrument. It would facilitate the early detection and characterization of glaucoma in patients and help in the monitoring of the progress of the disease and its treatment. This project aims to target this new technique specifically to the monitoring of the health and activity of the ganglion cells of the retina, the cells that are most affected by glaucoma. Dr. Ts’o then proposes to directly test how well this technique reveals glaucoma and its progression. These developments are designed to make this new technology most useful for the diagnosis and treatment of glaucoma.
Related Grants
National Glaucoma Research
Maldevelopment of Schlemm's Canal in Children with Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Revathi Balasubramanian, PhD
Current Organization
Columbia University
Maldevelopment of Schlemm's Canal in Children with Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Revathi Balasubramanian, PhD
Current Organization
Columbia University
National Glaucoma Research
Using Artificial Intelligence to Discover Genetic Risk Factors for Glaucoma Worsening
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Nazlee Zebardast, MD, MPH
Current Organization
Massachusetts Eye and Ear Infirmary
Using Artificial Intelligence to Discover Genetic Risk Factors for Glaucoma Worsening
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Nazlee Zebardast, MD, MPH
Current Organization
Massachusetts Eye and Ear Infirmary
National Glaucoma Research
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute